QTRX · Quanterix Corp · Executive Compensation
Market Cap
$121.07M
Shares
47.29M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Masoud Toloue | Ph.D. President and Chief Executive Officer Vandana Sriram Chief Financial Officer and Treasurer | $6,433,027 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Masoud Toloue | Ph.D. President and Chief Executive Officer Vandana Sriram Chief Financial Officer and Treasurer | $5,435,274 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Masoud Toloue | Ph.D. President and Chief Executive Officer Vandana Sriram Chief Financial Officer and Treasurer | $2,957,026 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer Michael A. Doyle Chief Financial Officer | $4,208,194 |
| Masoud Toloue | Ph.D. President and Chief Executive Officer; Former President of Quanterix and Diagnostics | $3,638,963 |
| John Fry | General Counsel and Secretary | $1,145,941 |
| Dawn Mattoon | Senior Vice President, Clinical Diagnostics William Geist Former Chief Operating Officer | $1,142,537 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer Michael A. Doyle Chief Financial Officer | $3,520,397 |
| William Geist | Chief Operating Officer | $2,484,582 |
| Amol Chaubal | Chief Financial Officer | $1,226,920 |
| John Fry | General Counsel and Secretary | $1,225,073 |
| Dawn Mattoon | Senior Vice President, Clinical Diagnostics William Geist Former Chief Operating Officer | $1,204,754 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Kevin Hrusovsky | Executive Chairman and Former Chief Executive Officer Michael A. Doyle Chief Financial Officer | $3,630,996 |
| John Fry | General Counsel and Secretary | $1,685,282 |
| Amol Chaubal | Chief Financial Officer | $1,343,425 |
| Dawn Mattoon | Senior Vice President, Clinical Diagnostics William Geist Former Chief Operating Officer | $885,613 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Kevin Hrusovsky | Chairman, President and Chief Executive Officer | $5,547,580 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Jason Faessler | Chief Financial Officer and Treasurer | Appointed | 2026-06-09 |
| Anthony Catalano | Chief Operating Officer | Appointed | 2026-05-26 |
| Everett Cunningham | Class II director | Appointed | 2026-01-08 |
| Masoud Toloue | member of the Board of Directors | Resigned | 2026-01-08 |
| Everett Cunningham | President and Chief Executive Officer | Appointed | 2026-01-08 |
| Masoud Toloue | President and Chief Executive Officer | Resigned | 2026-01-08 |
| Alan Sachs | Board | Appointed | 2025-11-20 |
| William Donnelly | Executive Chair of the Board | Appointed | 2025-11-20 |
| David Walt | Board of Directors | Retired | 2025-11-20 |
| Garret Hampton | Board | Appointed | 2025-11-20 |
| Paul Meister | Board of Directors | Retired | 2025-11-20 |
| Myla Lai-Goldman, MD | Class II director | Appointed | 2025-07-08 |
| Scott Mendel | Class I director | Appointed | 2025-07-08 |
| Martin Madaus, Ph.D. | board of directors of Quanterix | Resigned | 2025-07-08 |
| Sarah Hlavinka | board of directors of Quanterix | Resigned | 2025-07-08 |
| William P. Donnelly | Chairman of the Board | Appointed | 2025-03-28 |
| Ivana Magovčević-Liebisch | Class III director | Appointed | 2024-10-03 |
| Jeffrey T. Elliott | Class I director | Appointed | 2024-08-21 |
Key facts
CIK
1503274
CUSIP
74766Q101
13F (30d)
46 filings
46 filers
Visit website
Investor relations